SCP Ventures was born out of the Sustainergy Capital model of providing partners with not just capital, but value-added advice and capabilities that helps portfolio companies grow both domestically and in select international markets. SCP Ventures combines traditional investment backgrounds with deep industry specific knowledge in order to assist portfolio companies at all stages of growth.
SCP Ventures primarily invests in early-stage healthcare companies, with a focus on medical technologies and IT services, which are disrupting established industry verticals or filling niche segments of the market that are overlooked by larger corporations. We typically co-invest in Seed, Series A and Series B rounds. When we invest in earlier stages of a company’s lifecycle, we will look to continue to support the company’s future growth plans by reserving capital for follow-on capital raises.
The Partners at SCP Ventures as well as Sustainergy Capital have long operating and investing experience in both the US and Asia. The Partners leverage this experience and network to provide its portfolio companies access to East and Southeast Asia markets on the consumer and regulatory side as well as through strategic commercial partnerships.
SCP Ventures not only believes there are continuous and ever-changing opportunities within healthcare to drive significant investor value but we also believe that there are significant opportunities to improve access to healthcare.
Sustainergy Capital was founded in 2012 and is focused on investment opportunities in the natural resources sector, including renewable energies, minerals and mining, and infrastructure. Based in Hong Kong, the fund’s principal geographic focus is in the emerging markets of Southeast Asia where it sources and develops investment projects with local operating partners that have knowledge of the local regulatory, operating and legal environments. In 2015, Partners of Sustainergy Capital started a dedicated venture capital fund to principally invest in healthcare, FinTech and Consumer opportunities in the United States and Asia. The fund’s Partners have over 40 years of operating and investing experience in the healthcare sector, with particular focus on medical technologies, healthcare services and life sciences. The partnership leverages its operating and investment experience in Asia into growth and operating opportunities for its portfolio investments throughout the Asia-Pacific region. The venture capital arm of Sustainergy Capital is based in the San Francisco Bay Area.
Bryant Dun is a founding Partner at SCP Ventures, LLC as well as a founding Partner of Sustainergy Capital, Ltd, an emerging markets focused merchant bank. Bryant has extensive experience structuring and financing private equity and venture capital investments over his nearly 20-year career. He has closed over 35 private equity and venture capital transaction in the United States, Europe, and Asia. He was previously a Director at Park Avenue Equity Partners, LP, a New York based middle-market private equity fund as well as an investment banker in the Healthcare Investment Banking Group at Deutsche Bank Securities (formerly Deutsche Bank Alex. Brown). Bryant holds a BA in Economics from the University of Chicago and a joint EMBA from the Kellogg School of Management and Hong Kong University of Science and Technology.
Email: bryant.dun@scpventuresllc.com
Fred brings to SCP over 15 years of experience developing and commercializing breakthrough medical technologies in both developed and emerging markets. During his career, Fred launched dozens of products and brand campaigns, and built physicians and patient outreach programs globally. Fred’s broad-based leadership experiences includes vascular disease, cardiothoracic and general surgery, dentistry, and digital health. As an active early stage investor, Fred has also advised on several early investments in consumer health, dentistry, gastroenterology, and women’s health.
Fred received a Bachelor of Arts in Economics from Northwestern University and an MBA from the MIT Sloan School of Management. Prior to receiving his MBA, Fred worked as a management consultant and financial analyst. Fred also completed Stanford’s Biodesign executive program in 2016 and serves as an active mentor at startup accelerator Plug and Play.
Email: loremipsum@scpventuresllc.com
